Trends of Treatments for Pediatric Patients with Immune Thrombocytopenia in Japan
We observed an increasing trend in intravenous immunoglobulin use and second-line treatment, no change in corticosteroid use, and a decreasing trend in no-treatment approaches, using a national inpatient database. The hospital type might have affected the practice patterns. Clinicians might have chosen the optimal treatment for pediatric patients with immune thrombocytopenia considering several factors and patient backgrounds.
Authors
- Akira Ishiguro (ORCID: https://orcid.org/0000-0003-1867-3134)
- Makiko Mori (ORCID: https://orcid.org/0000-0003-3427-2461)
- Nobuaki Michihata (ORCID: https://orcid.org/0000-0003-3091-114X)
- Akifumi Endo (ORCID: https://orcid.org/0000-0002-8788-4042)
- Masato Yanagi (ORCID: https://orcid.org/0000-0003-0203-1954)
- Hideo Yasunaga (ORCID: https://orcid.org/0000-0002-6017-469X)
- Hidemi Toyoda (ORCID: https://orcid.org/0000-0002-4727-6050)
- Masamune Higashigawa (ORCID: https://orcid.org/0000-0002-2696-222X)
Institutions
- Suzuka University of Medical Science (JP)
- Mie University (JP)
- Shanghai Institute for Science of Science (CN)
- Saitama Children's Medical Center (JP)
- Sapporo Hokuyu Hospital (JP)
- Chiba Cancer Center (JP)
- Institute of Science Tokyo (JP)
- The University of Tokyo (JP)
Publication Details
- Journal
- Annals of Clinical Epidemiology
- Published
- 2025-06-19
- DOI
- https://doi.org/10.37737/ace.26001
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00